Page last updated: 2024-10-31

neostigmine and Bladder Diseases

neostigmine has been researched along with Bladder Diseases in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research Excerpts

ExcerptRelevanceReference
"Pregnancy is associated with many functional changes of the urinary bladder."1.51Effect of pregnancy on the cholinergic responses of the bladder: role of acetylcholinesterase. ( Mustafa, S, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mustafa, S1

Other Studies

1 other study available for neostigmine and Bladder Diseases

ArticleYear
Effect of pregnancy on the cholinergic responses of the bladder: role of acetylcholinesterase.
    International urology and nephrology, 2019, Volume: 51, Issue:1

    Topics: Acetylcholinesterase; Animals; Atropine; Cholinesterase Inhibitors; Disease Models, Animal; Female;

2019
chemdatabank.com